TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9355610
log Bayes Factor = 23.6995
Chromosome 6   position 167,383,075  (GRCh37) Explore rs9355610 on Ensembl!
Variant rs9355610 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.002 0.998
C44.3 Skin of other and unspecified parts of face
0.997 0.003 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.003 0.997
E10-E14 Diabetes mellitus
0.000 0.005 0.995
E10 Insulin-dependent diabetes mellitus
0.000 0.007 0.993
E50-E64 Other nutritional deficiencies
0.000 0.013 0.987
E05.9 Thyrotoxicosis, unspecified
0.000 0.015 0.985
E53 Deficiency of other B group vitamins
0.000 0.017 0.983
E53.8 Deficiency of other specified B group vitamins
0.000 0.020 0.980
E14 Unspecified diabetes mellitus
0.000 0.023 0.977
C44 Other malignant neoplasms of skin
0.977 0.023 0.000
C44.5 Skin of trunk
0.969 0.031 0.000
E07 Other disorders of thyroid
0.000 0.034 0.966
E10.9 Without complications
0.000 0.037 0.963
E10.4 With neurological complications
0.000 0.040 0.960
E07.9 Disorder of thyroid, unspecified
0.000 0.053 0.947
E14.9 Without complications
0.000 0.068 0.932
C43-C44 Melanoma and other malignant neoplasms of skin
0.928 0.072 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.081 0.919
C43 Malignant melanoma of skin
0.918 0.082 0.000
C43.5 Malignant melanoma of trunk
0.910 0.090 0.000
E14.4 With neurological complications
0.000 0.122 0.878
E10.2 With renal complications
0.000 0.128 0.872
E03.8 Other specified hypothyroidism
0.000 0.149 0.851
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.153 0.847
C43.3 Malignant melanoma of other and unspecified parts of face
0.822 0.178 0.000
E10.1 With ketoacidosis
0.000 0.178 0.822
C43.9 Malignant melanoma of skin, unspecified
0.814 0.186 0.000
C44.6 Skin of upper limb, including shoulder
0.813 0.187 0.000
E10.0 With coma
0.000 0.198 0.802
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.211 0.789
E53.9 Vitamin B deficiency, unspecified
0.000 0.229 0.771
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.236 0.763
C43.1 Malignant melanoma of eyelid, including canthus
0.758 0.242 0.000
E51 Thiamine deficiency
0.000 0.248 0.752
E14.3 With ophthalmic complications
0.000 0.248 0.752
C44.0 Skin of lip
0.748 0.251 0.000
E14.5 With peripheral circulatory complications
0.000 0.264 0.736
E61 Deficiency of other nutrient elements
0.000 0.266 0.734
E14.2 Withrenal complications
0.000 0.271 0.729
E10.6 With other specified complications
0.000 0.276 0.724
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.1 Congenital hypothyroidism without goitre
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.286 0.714
E10.7 With multiple complications
0.000 0.288 0.712
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.292 0.708
E63 Other nutritional deficiencies
0.000 0.292 0.708
E50 Vitamin A deficiency
0.000 0.292 0.708
E60 Dietary zinc deficiency
0.000 0.292 0.708
E59 Dietary selenium deficiency
0.000 0.292 0.708
E58 Dietary calcium deficiency
0.000 0.292 0.708
E54 Ascorbic acid deficiency
0.000 0.292 0.708
E52 Niacin deficiency [pellagra]
0.000 0.292 0.708
E53.1 Pyridoxine deficiency
0.000 0.295 0.705
E53.0 Riboflavin deficiency
0.000 0.295 0.705
C44.9 Malignant neoplasm of skin, unspecified
0.701 0.299 0.000
E14.7 With multiple complications
0.000 0.300 0.700
E14.0 With coma
0.000 0.300 0.700
C44.8 Overlapping lesion of skin
0.700 0.300 0.000
E14.8 With unspecified complications
0.000 0.301 0.699
E07.1 Dyshormogenetic goitre
0.000 0.307 0.692
E07.0 Hypersecretion of calcitonin
0.000 0.307 0.692
E14.1 With ketoacidosis
0.000 0.320 0.680
E56 Other vitamin deficiencies
0.000 0.327 0.673
C43.8 Overlapping malignant melanoma of skin
0.658 0.341 0.000
C43.0 Malignant melanoma of lip
0.658 0.341 0.000
E14.6 With other specified complications
0.000 0.356 0.644
E16 Other disorders of pancreatic internal secretion
0.000 0.361 0.639
E05.8 Other thyrotoxicosis
0.000 0.362 0.638
E10.8 With unspecified complications
0.000 0.365 0.635
C44.2 Skin of ear and external auricular canal
0.622 0.378 0.000
C43.4 Malignant melanoma of scalp and neck
0.622 0.378 0.000
E07.8 Other specified disorders of thyroid
0.000 0.388 0.612
E40-E46 Malnutrition
0.000 0.400 0.600
E51.2 Wernicke's encephalopathy
0.000 0.416 0.583
E61.2 Magnesium deficiency
0.000 0.430 0.570
E13 Other specified diabetes mellitus
0.000 0.433 0.567
E15 Nondiabetic hypoglycaemic coma
0.000 0.435 0.565
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.436 0.563
E65-E68 Obesity and other hyperalimentation
0.000 0.447 0.553
C43.6 Malignant melanoma of upper limb, including shoulder
0.553 0.447 0.000
E10.3 With ophthalmic complications
0.000 0.447 0.553
E16.2 Hypoglycaemia, unspecified
0.000 0.449 0.551
E51.9 Thiamine deficiency, unspecified
0.000 0.461 0.539
E51.8 Other manifestations of thiamine deficiency
0.000 0.461 0.539
E51.1 Beriberi
0.000 0.461 0.539
E06 Thyroiditis
0.000 0.463 0.537
E61.9 Deficiency of nutrient element, unspecified
0.000 0.474 0.526
E61.8 Deficiency of other specified nutrient elements
0.000 0.474 0.526
E61.7 Deficiency of multiple nutrient elements
0.000 0.474 0.526
E61.6 Vanadium deficiency
0.000 0.474 0.526
E61.5 Molybdenum deficiency
0.000 0.474 0.526
E61.4 Chromium deficiency
0.000 0.474 0.526
E61.3 Manganese deficiency
0.000 0.474 0.526
E61.0 Copper deficiency
0.000 0.474 0.526
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.488 0.512
E12.8 With unspecified complications
0.000 0.488 0.512
E12.7 With multiple complications
0.000 0.488 0.512
E12.6 With other specified complications
0.000 0.488 0.512
E12.5 With peripheral circulatory complications
0.000 0.488 0.512
E12.4 With neurological complications
0.000 0.488 0.512
E12.3 With ophthalmic complications
0.000 0.488 0.512
E12.2 With renal complications
0.000 0.488 0.512
E12.1 With ketoacidosis
0.000 0.488 0.512
E12.0 With coma
0.000 0.488 0.512
E50.9 Vitamin A deficiency, unspecified
0.000 0.492 0.507
E50.8 Other manifestations of vitamin A deficiency
0.000 0.492 0.507
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.492 0.507
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.492 0.507
E50.5 Vitamin A deficiency with night blindness
0.000 0.492 0.507
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.492 0.507
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.492 0.507
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.492 0.507
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.492 0.507
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.492 0.507
E63.9 Nutritional deficiency, unspecified
0.000 0.492 0.507
E63.8 Other specified nutritional deficiencies
0.000 0.492 0.507
E63.1 Imbalance of constituents of food intake
0.000 0.492 0.507
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.492 0.507
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.492 0.507
E64.8 Sequelae of other nutritional deficiencies
0.000 0.492 0.507
E64.3 Sequelae of rickets
0.000 0.492 0.507
E64.2 Sequelae of vitamin C deficiency
0.000 0.492 0.507
E64.1 Sequelae of vitamin A deficiency
0.000 0.492 0.507
E64.0 Sequelae of protein-energy malnutrition
0.000 0.492 0.507
E61.1 Iron deficiency
0.000 0.497 0.503
E10.5 With peripheral circulatory complications
0.000 0.509 0.491
E56.9 Vitamin deficiency, unspecified
0.000 0.517 0.482
E56.8 Deficiency of other vitamins
0.000 0.517 0.482
E56.0 Deficiency of vitamin E
0.000 0.517 0.482
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.519 0.481
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.541 0.458
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.541 0.458
E16.4 Abnormal secretion of gastrin
0.000 0.541 0.458
E16.3 Increased secretion of glucagon
0.000 0.541 0.458
E55 Vitamin D deficiency
0.000 0.547 0.452
E56.1 Deficiency of vitamin K
0.000 0.553 0.447
C43.2 Malignant melanoma of ear and external auricular canal
0.442 0.558 0.001
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.570 0.430
E45 Retarded development following protein-energy malnutrition
0.000 0.570 0.430
E43 Unspecified severe protein-energy malnutrition
0.000 0.570 0.430
E42 Marasmic kwashiorkor
0.000 0.570 0.430
E41 Nutritional marasmus
0.000 0.570 0.430
E40 Kwashiorkor
0.000 0.570 0.430
E13.8 With unspecified complications
0.000 0.593 0.406
E13.7 With multiple complications
0.000 0.593 0.406
E13.6 With other specified complications
0.000 0.593 0.406
E13.5 With peripheral circulatory complications
0.000 0.593 0.406
E13.4 With neurological complications
0.000 0.593 0.406
E13.2 With renal complications
0.000 0.593 0.406
E13.1 With ketoacidosis
0.000 0.593 0.406
E13.0 With coma
0.000 0.593 0.406
E66 Obesity
0.000 0.603 0.397
E67 Other hyperalimentation
0.000 0.603 0.397
E68 Sequelae of hyperalimentation
0.000 0.603 0.397
E16.1 Other hypoglycaemia
0.000 0.609 0.391
E06.5 Other chronic thyroiditis
0.000 0.615 0.385
E06.4 Drug-induced thyroiditis
0.000 0.615 0.385
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.615 0.385
E06.0 Acute thyroiditis
0.000 0.615 0.385
E13.3 With ophthalmic complications
0.000 0.618 0.382
E06.3 Autoimmune thyroiditis
0.000 0.620 0.380
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.639 0.361
C44.7 Skin of lower limb, including hip
0.343 0.657 0.000
E06.1 Subacute thyroiditis
0.000 0.658 0.342
E55.0 Rickets, active
0.000 0.675 0.324
C44.1 Skin of eyelid, including canthus
0.324 0.676 0.000
E66.8 Other obesity
0.000 0.678 0.322
E46 Unspecified protein-energy malnutrition
0.000 0.684 0.315
E44.1 Mild protein-energy malnutrition
0.000 0.691 0.308
E44.0 Moderate protein-energy malnutrition
0.000 0.691 0.308
E13.9 Without complications
0.000 0.699 0.300
E20-E35 Disorders of other endocrine glands
0.000 0.711 0.289
E04 Other non-toxic goitre
0.000 0.712 0.288
E06.9 Thyroiditis, unspecified
0.000 0.714 0.285
E66.1 Drug-induced obesity
0.000 0.715 0.285
E67.8 Other specified hyperalimentation
0.000 0.715 0.284
E67.3 Hypervitaminosis D
0.000 0.715 0.284
E67.2 Megavitamin-B6 syndrome
0.000 0.715 0.284
E67.1 Hypercarotenaemia
0.000 0.715 0.284
E67.0 Hypervitaminosis A
0.000 0.715 0.284
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.729 0.271
E21.3 Hyperparathyroidism, unspecified
0.000 0.747 0.253
E66.0 Obesity due to excess calories
0.000 0.752 0.248
E65 Localised adiposity
0.001 0.765 0.234
L43.9 Lichen planus, unspecified
0.000 0.769 0.231
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.770 0.230
E04.0 Non-toxic diffuse goitre
0.000 0.777 0.223
E25 Adrenogenital disorders
0.000 0.784 0.216
E26 Hyperaldosteronism
0.000 0.789 0.211
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.793 0.207
E32 Diseases of thymus
0.000 0.793 0.207
E31 Polyglandular dysfunction
0.000 0.793 0.207
E30 Disorders of puberty, not elsewhere classified
0.000 0.793 0.207
E04.8 Other specified non-toxic goitre
0.000 0.793 0.207
E28 Ovarian dysfunction
0.000 0.797 0.203
E21.4 Other specified disorders of parathyroid gland
0.000 0.806 0.194
E21.2 Other hyperparathyroidism
0.000 0.809 0.191
E20 Hypoparathyroidism
0.000 0.814 0.185
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.816 0.184
E21.0 Primary hyperparathyroidism
0.000 0.819 0.181
E24 Cushing's syndrome
0.000 0.821 0.179
E28.3 Primary ovarian failure
0.000 0.823 0.177
E29 Testicular dysfunction
0.000 0.831 0.169
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.837 0.163
C43.7 Malignant melanoma of lower limb, including hip
0.163 0.837 0.000
E22 Hyperfunction of pituitary gland
0.000 0.843 0.157
E23 Hypofunction and other disorders of pituitary gland
0.000 0.843 0.157
E26.0 Primary hyperaldosteronism
0.000 0.844 0.156
E25.9 Adrenogenital disorder, unspecified
0.000 0.845 0.155
E25.8 Other adrenogenital disorders
0.000 0.845 0.155
E26.9 Hyperaldosteronism, unspecified
0.000 0.848 0.152
E26.8 Other hyperaldosteronism
0.000 0.848 0.152
E26.1 Secondary hyperaldosteronism
0.000 0.848 0.152
E30.9 Disorder of puberty, unspecified
0.000 0.851 0.149
E30.8 Other disorders of puberty
0.000 0.851 0.149
E30.1 Precocious puberty
0.000 0.851 0.149
E30.0 Delayed puberty
0.000 0.851 0.149
E31.9 Polyglandular dysfunction, unspecified
0.000 0.851 0.149
E31.8 Other polyglandular dysfunction
0.000 0.851 0.149
E31.1 Polyglandular hyperfunction
0.000 0.851 0.149
E31.0 Autoimmune polyglandular failure
0.000 0.851 0.149
E32.9 Disease of thymus, unspecified
0.000 0.851 0.149
E32.8 Other diseases of thymus
0.000 0.851 0.149
E32.1 Abscess of thymus
0.000 0.851 0.149
E32.0 Persistent hyperplasia of thymus
0.000 0.851 0.149
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.851 0.149
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.851 0.149
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.851 0.149
E28.9 Ovarian dysfunction, unspecified
0.000 0.854 0.146
E28.8 Other ovarian dysfunction
0.000 0.854 0.146
E28.1 Androgen excess
0.000 0.854 0.146
E28.0 Oestrogen excess
0.000 0.854 0.146
C44.4 Skin of scalp and neck
0.145 0.855 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.862 0.138
E20.8 Other hypoparathyroidism
0.000 0.867 0.133
E20.1 Pseudohypoparathyroidism
0.000 0.867 0.133
E20.0 Idiopathic hypoparathyroidism
0.000 0.867 0.133
E04.1 Non-toxic single thyroid nodule
0.000 0.867 0.133
E22.0 Acromegaly and pituitary gigantism
0.000 0.870 0.130
E24.8 Other Cushing's syndrome
0.000 0.871 0.128
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.871 0.128
E24.3 Ectopic ACTH syndrome
0.000 0.871 0.128
E24.1 Nelson's syndrome
0.000 0.871 0.128
L43 Lichen planus
0.000 0.873 0.127
E34 Other endocrine disorders
0.000 0.874 0.126
E24.9 Cushing's syndrome, unspecified
0.000 0.874 0.126
E23.0 Hypopituitarism
0.000 0.876 0.124
E29.9 Testicular dysfunction, unspecified
0.000 0.878 0.121
E29.8 Other testicular dysfunction
0.000 0.878 0.121
E29.0 Testicular hyperfunction
0.000 0.878 0.121
E24.0 Pituitary-dependent Cushing's disease
0.000 0.881 0.119
E24.2 Drug-induced Cushing's syndrome
0.000 0.885 0.115
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.887 0.113
E22.8 Other hyperfunction of pituitary gland
0.000 0.887 0.113
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.887 0.113
E23.1 Drug-induced hypopituitarism
0.000 0.887 0.113
E20.9 Hypoparathyroidism, unspecified
0.000 0.888 0.111
E04.9 Non-toxic goitre, unspecified
0.000 0.893 0.107
E23.2 Diabetes insipidus
0.000 0.895 0.105
L43.8 Other lichen planus
0.000 0.897 0.103
E27 Other disorders of adrenal gland
0.000 0.901 0.098
E23.7 Disorder of pituitary gland, unspecified
0.000 0.902 0.097
L43.3 Subacute (active) lichen planus
0.000 0.909 0.091
L43.2 Lichenoid drug reaction
0.000 0.909 0.091
L43.1 Bullous lichen planus
0.000 0.909 0.091
L43.0 Hypertrophic lichen planus
0.000 0.909 0.091
E34.5 Androgen resistance syndrome
0.000 0.909 0.090
E34.4 Constitutional tall stature
0.000 0.909 0.090
E34.3 Short stature, not elsewhere classified
0.000 0.909 0.090
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.909 0.090
E34.1 Other hypersecretion of intestinal hormones
0.000 0.909 0.090
G12.2 Motor neuron disease
0.000 0.915 0.085
E29.1 Testicular hypofunction
0.000 0.917 0.083
E22.1 Hyperprolactinaemia
0.000 0.919 0.080
E34.9 Endocrine disorder, unspecified
0.000 0.921 0.079
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.922 0.077
E23.6 Other disorders of pituitary gland
0.000 0.923 0.077
G12 Spinal muscular atrophy and related syndromes
0.000 0.925 0.075
E34.8 Other specified endocrine disorders
0.000 0.926 0.073
E27.5 Adrenomedullary hyperfunction
0.000 0.929 0.071
E27.0 Other adrenocortical overactivity
0.000 0.929 0.071
E70-E90 Metabolic disorders
0.000 0.929 0.071
E27.9 Disorder of adrenal gland, unspecified
0.000 0.930 0.070
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.930 0.070
E55.9 Vitamin D deficiency, unspecified
0.001 0.930 0.069
G11 Hereditary ataxia
0.000 0.931 0.069
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.000 0.931 0.069
E28.2 Polycystic ovarian syndrome
0.000 0.932 0.068
G11.9 Hereditary ataxia, unspecified
0.000 0.933 0.067
E34.0 Carcinoid syndrome
0.000 0.934 0.066
E83 Disorders of mineral metabolism
0.000 0.935 0.065
E27.1 Primary adrenocortical insufficiency
0.000 0.937 0.063
E83.3 Disorders of phosphorus metabolism
0.000 0.937 0.063
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.938 0.061
G11.4 Hereditary spastic paraplegia
0.000 0.940 0.060
Z95.0 Presence of cardiac pacemaker
0.000 0.942 0.058
E79 Disorders of purine and pyrimidine metabolism
0.000 0.943 0.057
E83.5 Disorders of calcium metabolism
0.000 0.944 0.056
G12.9 Spinal muscular atrophy, unspecified
0.000 0.946 0.054
G12.8 Other spinal muscular atrophies and related syndromes
0.000 0.946 0.054
G12.1 Other inherited spinal muscular atrophy
0.000 0.946 0.054
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
0.000 0.946 0.054
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.947 0.052
G10 Huntington's disease
0.000 0.948 0.052
E83.1 Disorders of iron metabolism
0.000 0.948 0.052
E84 Cystic fibrosis
0.000 0.949 0.051
E77 Disorders of glycoprotein metabolism
0.000 0.949 0.051
E76 Disorders of glycosaminoglycan metabolism
0.000 0.949 0.051
E72 Other disorders of amino-acid metabolism
0.000 0.949 0.051
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.949 0.051
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.949 0.051
G14 Postpolio syndrome
0.000 0.950 0.050
E88 Other metabolic disorders
0.000 0.950 0.050
G11.8 Other hereditary ataxias
0.000 0.951 0.049
G11.3 Cerebellar ataxia with defective DNA repair
0.000 0.951 0.049
G11.2 Late-onset cerebellar ataxia
0.000 0.951 0.049
G11.1 Early-onset cerebellar ataxia
0.000 0.951 0.049
G11.0 Congenital nonprogressive ataxia
0.000 0.951 0.049
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
0.000 0.951 0.049
E27.2 Addisonian crisis
0.000 0.952 0.048
E74 Other disorders of carbohydrate metabolism
0.000 0.952 0.048
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.953 0.047
E83.8 Other disorders of mineral metabolism
0.000 0.953 0.047
E83.2 Disorders of zinc metabolism
0.000 0.953 0.047
E83.0 Disorders of copper metabolism
0.000 0.953 0.047
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.953 0.047
E70 Disorders of aromatic amino-acid metabolism
0.000 0.953 0.046
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.957 0.043
E78.2 Mixed hyperlipidaemia
0.000 0.957 0.043
E27.8 Other specified disorders of adrenal gland
0.000 0.958 0.041
E73 Lactose intolerance
0.000 0.958 0.042
E88.2 Lipomatosis, not elsewhere classified
0.000 0.959 0.041
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.959 0.041
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.959 0.041
E79.1 Lesch-Nyhan syndrome
0.000 0.959 0.041
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.959 0.041
E75.5 Other lipid storage disorders
0.000 0.960 0.040
E85 Amyloidosis
0.000 0.961 0.039
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.962 0.038
E75.6 Lipid storage disorder, unspecified
0.000 0.962 0.038
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.962 0.038
E75.3 Sphingolipidosis, unspecified
0.000 0.962 0.038
E75.1 Other gangliosidosis
0.000 0.962 0.038
E75.0 GM2 gangliosidosis
0.000 0.962 0.038
E75.2 Other sphingolipidosis
0.000 0.963 0.037
E78.4 Other hyperlipidaemia
0.000 0.963 0.037
E71.3 Disorders of fatty-acid metabolism
0.000 0.963 0.036
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.963 0.036
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.963 0.036
E71.0 Maple-syrup-urine disease
0.000 0.963 0.036
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.963 0.036
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.963 0.036
E72.5 Disorders of glycine metabolism
0.000 0.963 0.036
E72.4 Disorders of ornithine metabolism
0.000 0.963 0.036
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.963 0.036
E72.2 Disorders of urea cycle metabolism
0.000 0.963 0.036
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.963 0.036
E72.0 Disorders of amino-acid transport
0.000 0.963 0.036
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.963 0.036
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.963 0.036
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.963 0.036
E76.2 Other mucopolysaccharidoses
0.000 0.963 0.036
E76.1 Mucopolysaccharidosis, type II
0.000 0.963 0.036
E76.0 Mucopolysaccharidosis, type I
0.000 0.963 0.036
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.963 0.036
E77.8 Other disorders of glycoprotein metabolism
0.000 0.963 0.036
E77.1 Defects in glycoprotein degradation
0.000 0.963 0.036
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.963 0.036
E84.9 Cystic fibrosis, unspecified
0.000 0.963 0.036
E84.8 Cystic fibrosis with other manifestations
0.000 0.963 0.036
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.963 0.036
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.963 0.036
E88.8 Other specified metabolic disorders
0.000 0.964 0.036
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
0.000 0.964 0.035
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema
0.000 0.964 0.035
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease
0.000 0.964 0.035
G13.0 Paraneoplastic neuromyopathy and neuropathy
0.000 0.964 0.035
E88.9 Metabolic disorder, unspecified
0.000 0.964 0.035
E89.2 Postprocedural hypoparathyroidism
0.000 0.965 0.035
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.966 0.034
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.966 0.034
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.966 0.034
E74.2 Disorders of galactose metabolism
0.000 0.966 0.034
E74.1 Disorders of fructose metabolism
0.000 0.966 0.034
E74.0 Glycogen storage disease
0.000 0.966 0.034
E78.8 Other disorders of lipoprotein metabolism
0.000 0.966 0.034
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.966 0.033
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.966 0.033
E70.2 Disorders of tyrosine metabolism
0.000 0.966 0.033
E70.1 Other hyperphenylalaninaemias
0.000 0.966 0.033
E70.0 Classical phenylketonuria
0.000 0.966 0.033
E88.3 Tumour lysis syndrome
0.000 0.969 0.031
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.969 0.031
E78.1 Pure hyperglyceridaemia
0.000 0.969 0.031
E78.3 Hyperchylomicronaemia
0.000 0.969 0.031
E73.8 Other lactose intolerance
0.000 0.970 0.030
E73.1 Secondary lactase deficiency
0.000 0.970 0.030
E73.0 Congenital lactase deficiency
0.000 0.970 0.030
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.970 0.029
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.970 0.029
E89.5 Postprocedural testicular hypofunction
0.000 0.970 0.029
E89.1 Postprocedural hypoinsulinaemia
0.000 0.970 0.029
E70.3 Albinism
0.000 0.971 0.029
E78.6 Lipoprotein deficiency
0.000 0.971 0.029
E85.8 Other amyloidosis
0.000 0.972 0.028
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.972 0.028
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.972 0.028
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.972 0.028
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.973 0.027
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.973 0.027
E85.4 Organ-limited amyloidosis
0.000 0.974 0.026
E89.0 Postprocedural hypothyroidism
0.000 0.974 0.026
E85.9 Amyloidosis, unspecified
0.000 0.975 0.025
E89.3 Postprocedural hypopituitarism
0.000 0.976 0.024
E85.3 Secondary systemic amyloidosis
0.000 0.977 0.023
E89.4 Postprocedural ovarian failure
0.000 0.977 0.022
E73.9 Lactose intolerance, unspecified
0.000 0.979 0.021
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.979 0.021
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.985 0.015
E80.5 Crigler-Najjar syndrome
0.000 0.985 0.015
E80.3 Defects of catalase and peroxydase
0.000 0.985 0.015
E80.0 Hereditary erythropoietic porphyria
0.000 0.985 0.015
K50.9 Crohn's disease, unspecified
0.000 0.986 0.014
E80.2 Other porphyria
0.000 0.986 0.013
E80.1 Porphyria cutanea tarda
0.000 0.987 0.013
L40-L45 Papulosquamous disorders
0.000 0.987 0.013
Z45.0 Adjustment and management of cardiac pacemaker
0.000 0.987 0.013
E80.6 Other disorders of bilirubin metabolism
0.000 0.988 0.012
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.989 0.011
E83.4 Disorders of magnesium metabolism
0.000 0.990 0.010
E86 Volume depletion
0.000 0.990 0.010
K50 Crohn's disease [regional enteritis]
0.000 0.990 0.010
L03.0 Cellulitis of finger and toe
0.000 0.990 0.010
K50.8 Other Crohn's disease
0.000 0.990 0.010
L41 Parapsoriasis
0.000 0.990 0.009
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.990 0.009
E11 Non-insulin-dependent diabetes mellitus
0.000 0.991 0.009
L44 Other papulosquamous disorders
0.000 0.991 0.008
K50.0 Crohn's disease of small intestine
0.000 0.991 0.008
E78.5 Hyperlipidaemia, unspecified
0.000 0.992 0.008
E11.0 With coma
0.000 0.992 0.008
E80.4 Gilbert's syndrome
0.000 0.993 0.007
D23.3 Skin of other and unspecified parts of face
0.000 0.993 0.007
L42 Pityriasis rosea
0.000 0.993 0.007
L41.9 Parapsoriasis, unspecified
0.000 0.993 0.007
L41.8 Other parapsoriasis
0.000 0.993 0.007
L41.5 Retiform parapsoriasis
0.000 0.993 0.007
L41.4 Large plaque parapsoriasis
0.000 0.993 0.007
L41.3 Small plaque parapsoriasis
0.000 0.993 0.007
L41.2 Lymphomatoid papulosis
0.000 0.993 0.007
L41.1 Pityriasis lichenoides chronica
0.000 0.993 0.007
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.993 0.007
E11.7 With multiple complications
0.000 0.993 0.006
L44.9 Papulosquamous disorder, unspecified
0.000 0.993 0.006
L44.8 Other specified papulosquamous disorders
0.000 0.993 0.006
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.993 0.006
L44.3 Lichen ruber moniliformis
0.000 0.993 0.006
L44.2 Lichen striatus
0.000 0.993 0.006
L44.1 Lichen nitidus
0.000 0.993 0.006
R16.1 Splenomegaly, not elsewhere classified
0.000 0.994 0.006
K52.1 Toxic gastro-enteritis and colitis
0.000 0.994 0.006
E11.8 With unspecified complications
0.000 0.994 0.006
E66.9 Obesity, unspecified
0.000 0.994 0.006
L44.0 Pityriasis rubra pilaris
0.000 0.994 0.005
C32.1 Supraglottis
0.005 0.995 0.000
E11.2 With renal complications
0.000 0.995 0.005
C50.8 Overlapping lesion of breast
0.005 0.995 0.000
S02.60 Fracture of mandible (closed)
0.000 0.995 0.005
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified
0.000 0.995 0.005
C32.0 Glottis
0.005 0.995 0.000
I89.0 Lymphoedema, not elsewhere classified
0.000 0.995 0.005
Y60.0 During surgical operation
0.005 0.995 0.000
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
0.005 0.995 0.000
E11.6 With other specified complications
0.000 0.995 0.005
C32 Malignant neoplasm of larynx
0.005 0.995 0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances
0.000 0.995 0.005
M79.67 Pain in limb (Ankle and foot)
0.000 0.995 0.005
R16 Hepatomegaly and splenomegaly, not elsewhere classified
0.000 0.995 0.005
K50.1 Crohn's disease of large intestine
0.000 0.995 0.004

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.